Assessment of the HScore as a predictor of disease outcome in patients with COVID-19
Abstract Severe coronavirus disease 2019 (COVID-19) accompanies hypercytokinemia, similar to secondary hemophagocytic lymphohistiocytosis (sHLH). We aimed to find if HScore could predict disease severity in COVID-19. HScore was calculated in hospitalized children and adult patients with a proven dia...
Main Authors: | Mohammadreza Bordbar, Anahita Sanaei Dashti, Ali Amanati, Eslam Shorafa, Yasaman Mansoori, Seyed Javad Dehghani, Hossein Molavi Vardanjani |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-021-01706-0 |
Similar Items
-
Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
by: Federica Mannino, et al.
Published: (2020-11-01) -
Predictors of mortality in COVID-19 disease
by: Srikanth AK, et al.
Published: (2022-06-01) -
Immunological mechanisms of the nucleocapsid protein in COVID-19
by: Fahime Edalat, et al.
Published: (2024-02-01) -
Cytokine profiling in Iranian patients with COVID-19; association with clinical severity
by: Saeid Taghiloo, et al.
Published: (2021-03-01) -
Temporal cytokine storm dynamics in dengue infection predicts severity
by: Puneet Bhatt, et al.
Published: (2024-03-01)